CAS 1118567-05-7
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
8 produits trouvés.
Bexagliflozin
CAS :(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-(2-cyclopropoxyethoxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triolFormule :C24H29ClO7Degré de pureté :98%Masse moléculaire :464.94EGT1442
CAS :Formule :C24H29ClO7Degré de pureté :99%Couleur et forme :SolidMasse moléculaire :464.9359Ref: IN-DA008TOL
50gÀ demander50mg62,00€100mg66,00€250mg113,00€1g127,00€5g180,00€10g322,00€25g537,00€Bexagliflozin
CAS :Bexagliflozin (EGT1442) is a potent, selective sodium glucose co-transporter 2 (SGLT2) inhibitor with IC50 values of 2 nM for human SGLT2.Formule :C24H29ClO7Degré de pureté :98.99% - 99.89%Couleur et forme :SolidMasse moléculaire :464.94Ref: TM-T7217
1mg56,00€2mg95,00€5mg118,00€1mL*10mM (DMSO)120,00€10mg168,00€25mg348,00€50mg527,00€100mg785,00€Bexagliflozin
CAS :Produit contrôléFormule :C24H29ClO7Couleur et forme :NeatMasse moléculaire :464.94Bexagliflozin
CAS :Bexagliflozin is a drug that is used to treat type II diabetes in adults. It helps to control blood sugar levels by inhibiting the enzyme DPP-IV and increasing insulin release from the pancreas. Bexagliflozin has been shown to be effective in lowering blood sugar levels in patients with chronic kidney disease and cancer, as well as those with a body mass index (BMI) of 30 or higher. This drug is an oral hypoglycaemic agent that can be used for diagnostic purposes. It has also been shown to be clinically effective for the treatment of diabetic nephropathy and diabetic retinopathy. The enantiomers of bexagliflozin can be differentiated according to their pharmacological properties, which may allow for more targeted therapy.Formule :C24H29ClO7Degré de pureté :Min. 95%Masse moléculaire :464.94 g/mol
